federal_register: 2020-18263
This data as json
| document_number | title | type | abstract | publication_date | pub_year | pub_month | html_url | pdf_url | agency_names | agency_ids | excerpts |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2020-18263 | Postmarketing Safety Reports for Approved New Animal Drugs; Electronic Submission Requirements; Correction | Rule | The Food and Drug Administration (FDA, the Agency, or we) is correcting a final rule that published in the Federal Register of July 29, 2020. That final rule requires electronic submission of certain postmarketing safety reports for approved new animal drugs and provides a procedure for requesting a temporary waiver of the electronic submission requirement. Table 2 of the final rule published with errors and this document corrects those errors. We are placing a corrected copy of the final rule in the docket. | 2020-09-22 | 2020 | 9 | https://www.federalregister.gov/documents/2020/09/22/2020-18263/postmarketing-safety-reports-for-approved-new-animal-drugs-electronic-submission-requirements | https://www.govinfo.gov/content/pkg/FR-2020-09-22/pdf/2020-18263.pdf | Health and Human Services Department; Food and Drug Administration | 221,199 | The Food and Drug Administration (FDA, the Agency, or we) is correcting a final rule that published in the Federal Register of July 29, 2020. That final rule requires electronic submission of certain postmarketing safety reports for approved new animal... |